Mithra Pharmaceuticals earnings
Annual earnings per share (EUR per share, as reported)
| Fiscal year | Period end | Diluted EPS | Basic EPS | Filed |
|---|---|---|---|---|
| 2022 | 2022-12-31 | €-1.22 | €-1.22 | 2026-06-19T06:05:05Z |
| 2021 | 2021-12-31 | €-2.69 | €-2.69 | 2026-06-19T06:05:05Z |
Revenue & profit (EUR)
| Concept | 2022 | 2021 |
|---|---|---|
| Revenue | €67.0M | €22.7M |
| Profit for the year | -€59.6M | -€116.9M |
Methodology
Earnings per share comes from ifrs-full:DilutedEarningsLossPerShare /
ifrs-full:BasicEarningsLossPerShare; revenue from
ifrs-full:Revenue and profit from ifrs-full:ProfitLoss,
as tagged in Mithra Pharmaceuticals's ESEF annual reports (source:
filings.xbrl.org).
Figures are in EUR, as reported. Not investment advice.